Edwards Lifesciences v Meril (CFI, 5 March 2024)
| Date | 5 March 2024 |
|---|---|
| Court | CFI |
| Division | Munich (DE) Local Division |
| Type of action | Generic application |
| Registry reference | App_7662/2024 · ORD_8519/2024 |
| Parties | Edwards Lifesciences Corporation |
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By an order of 5 March 2024 (UPC_CFI_15/2023, ACT_459987/2023, CC_584916/2023, CC_585030/2023, App_7662/2024), the presiding judge and judge-rapporteur of the Munich Local Division (M. Zigann), in the infringement action on EP 3 646 825 brought by Edwards Lifesciences Corporation against Meril GmbH and Meril Life Sciences Pvt Ltd, held that no decision was needed on the requests for an in-person interim conference and court-provided simultaneous interpretation, which the claimant had withdrawn, and admitted the private interpreters to the video conference. The headnotes of the order set out useful principles on the format of the interim conference and on interpretation.
Question
When can an interim conference planned as a video conference be held in person, and can a claimant that chose German for a patent granted in English obtain court-provided simultaneous interpretation into English?
Decision
According to the headnotes, given the additional burden on all participants, an in-person conference requires a showing of absolute necessity. A claimant that chose German as the language of the proceedings, for a patent granted in English and between international parties, must itself resolve the tension between that choice and its request for interpretation, although it remains free to arrange interpretation at its own cost (Rule 109.2 RoP). After a preliminary order of 15 February 2024 indicating that the requests would probably be refused, the claimant withdrew them. The parties agreed to engage an interpreter under Rule 109.4 and share the cost equally. The division found that no decision was needed and closed the workstream.
Key points for practice
- Practical point: a claimant that chooses German for a patent in English must live with that choice, interpretation remains available at its own cost or on agreed cost sharing.
Provisions applied
- Rules of Procedure
- Rules 105.2, 109.1, 109.2 and 109.4
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Going further
Lexicon: Written procedure (UPC), Court fees and costs (UPC).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Proceedings
Parties
- claimantEdwards Lifesciences Corporation41 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
What the record states
- Nature of the act
- Generic application
- Outcome (Dhenne Avocats summary)
- Les demandes ayant été retirées, il n'y a plus lieu de statuer. Les interprètes privés sont admis à la visioconférence et l'incident est clos.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 3 646 825mentioned in: Dhenne Avocats analysis Follow this patent
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 3 646 825A system comprising a prosthetic valve and a delivery catheter recorded proprietor: Edwards Lifesciences Corp | Mentioned in the analysis (role not qualified) Also mentioned in 32 other decision(s): Edwards Lifesciences v Meril Life Sciences (CFI, 15 November 2024) · Meril Italy v Edwards Lifesciences (CFI, 19 July 2024) · Meril v Edwards Lifesciences (CFI, 19 July 2024) · Meril Italy v Edwards Lifesciences (CoA, 25 November 2025) · Edwards Lifesciences v Sintec (CFI, 5 September 2025) · Meril Italy v SWAT Medical (CoA, 5 May 2025) · Meril v SWAT Medical (CoA, 5 May 2025) · Meril Life Sciences v SWAT Medical (CoA, 5 May 2025) | not recorded | not recorded | not recorded | Espacenet · European Patent Register existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically) mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.